It has been further demonstrated that there is a positive feedback loop between mTOR activation and the binding of CXCL12 to its receptor CXCR4—inhibiting the mTOR activity may prevent cancer metastasis because it subsequently decreases CXCL12 interaction. Here, CXCL12 is linked to cancer.